Pita Navarro’s Post

Did you know? Our tandem UTI testing at Advanta Genetics combines PCR and Culture methods for superior diagnostic accuracy. With PCR, you get next-morning results, enabling early treatment without waiting for preliminary culture results. When the culture is complete, you'll have detailed susceptibility data for precise, data-driven treatment adjustments. This approach ensures better patient outcomes through good stewardship and informed decisions. Contact us to learn more. #UTITesting #PatientCare #AdvantaGenetics #HealthcareInnovation

🌟 Live from the Regeneron's Digital Biomarkers Summit 🌟 During the session "DHTs in Chronic Pain Studies: Collaborative Development between Eli Lilly and Company and Empatica," Brian Winger, Associate VP of Digital Health R&D at Eli Lily, reminds us that #dBMs can potentially eliminate placebo responses. 💊 A good reminder that strong scientific rationales for innovation are often the quickest path to adoption. 💪🏽 #Regeneron #DigitalBiomakersSummit #ClinicalOperations #ClinicalResearch #ClinicalDevelopment

Health is not one-size-fits-all, which is exactly why we offer detailed insights into your unique biology, helping you make informed decisions for a healthier life. Leverage advanced biomarker analytics to identify high-risk patients, help predict adverse events, and deliver proactive interventions. 📈 👩🏽⚕️👨🏼⚕️ 🔗 Discover more at MolecularYou.com. #MolecularYou #BloodTest #Health #Wellness #BioHack #CustomHealth #BioScience #HealthyLiving

Honored to be here at the Personalized Medicine Coalition Conference and honored to help by brother, who is facing #glioblastoma, engage in #informeddecisionmaking. Molecular testing companies - your patient portals (if you have one) aren’t helping patients engage in shared decision making. Shared decision-making is ✅Good for patients ✅Good for providers ✅Good for business RabbleHealth can help. My Calendly is in the comments. #wevegotworktodo

Forbes USA highlights our Founder and Executive Chairman, Brian Meshkin and his mission to transform healthcare from symptomatology-based treatment to a predictive model.  The importance of Proove Genomics Inc. and Outcomeus' missions are detailed, including their proven-effective resolutions to addressing America's leading causes of preventable death and pain. https://lnkd.in/gdV8pstQ #PredictiveHealthcare #OpioidCrisis #Painmanagement #Addictiontreatment

🌟 Shaping a Future of Health Empowerment! Imagine a world where DNA testing is as commonplace as a routine checkup. 🧬💚 That's our vision at Genetix! We're dedicated to making genetic insights accessible to all, uncovering predispositions and profiles that empower YOU to manage your well-being like never before. But we're not stopping there. 🚀 Our mission extends to establishing pharmacogenomics (PGx) as the gold standard before prescribing medications. Imagine a healthcare landscape where precision meets prescription, optimizing treatment for chronic conditions and revolutionizing personalized medicine. Join us on this remarkable journey towards a healthier, more empowered future. 🌐🔬 Let's unlock the potential within our DNA and reshape the way we approach health and care! 💪🌍 #HealthEmpowerment #GeneticRevolution #PGxAdvocates #PersonalizedMedicine #FutureOfHealthcare

As s patient: How #Pharmacogenomics is Changing My Treatment and Health? (1th) As a #patient navigating the complexities of healthcare, one of the most exciting developments I’ve come across is pharmacogenomics (PGx). This groundbreaking field focuses on how my unique genetic makeup influences how I respond to medications. 💎By understanding these #genetic variations, my healthcare providers can personalize my treatment plan to maximize its effectiveness and minimize side effects. 💎By tailoring my treatment plan to my genetic profile, PGx has improved the effectiveness of my medications, reduced side effects, and enhanced my overall quality of life. How? Good question. For more information, follow us in upcoming posts on #LinkedIn: https://lnkd.in/gkYjAkj6 #pharmacogenimics #patient #healthcareprofessionals

From curing life-threatening conditions to detecting risks of disease from a blood sample, genetic innovation has never been more promising. Business Group on Health hosted an Innovation Showcase this week on #Genetics in Medicine that explored how employers can transform treatment paradigms, enhance patient outcomes, revolutionize preventive health strategies and improve overall employee well-being by integrating genetic advancements into their health care strategy. For members who missed the live event, click here for the recording. https://okt.to/b6CQsT

The first session of the masterclass: Optimizing the use of #immunotherapy in #cancercare management has begun! Thank you Dr. Aung Naing Dr. David Mosko & Dr. Julian Molina! Abdul Rahman Jazieh, MD, MPH JIPO Editors #IOMasterclass23

Today is an exciting day as we proudly introduce the first-ever "Guidelines for the Management of α-Thalassaemia"! This ground-breaking resource is designed specifically for #healthcareprofessionals, #researchers, and anyone with a vested interest in caring for individuals with α-#thalassaemia. As a complex genetic and hereditary #haemoglobinopathy, α-thalassaemia often goes undiagnosed, leading people to seek help only when #complications have advanced. These guidelines represent a significant milestone in thalassaemia history and are filled with essential knowledge to aid in the diagnosis and management of Non-Transfusion Dependent α-Thalassaemia. By making this invaluable resource accessible, we're taking a monumental step towards improving #patientcare and gaining a deeper understanding of the overall impact of α-thalassaemia on patient quality of life and social integration. Download the α-thalassaemia Guidelines today via the link below! 👇 https://lnkd.in/eZNc7skX